Science Explorer Back to mapMap
Discussion
Researcher · Dana-Farber Cancer Institute · United States

Gordon James Freeman

Gordon James Freeman publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

ORCID 0000-0002-7210-5616 OpenAlex
World rank
#154
of 7,710,434 ranked researchers
Rank in United States
#80
of 1,627,098
Works
1,109
Citations
134k
Citations per work
120.7
h-index
177
i10-index 423Top 0.1% in Immunology
Gordon James Freeman

What does Gordon James Freeman research?

Gordon James Freeman's work is mostly in Immunology and Microbiology (41%), Medicine (30%), Biochemistry, Genetics and Molecular Biology (9%).

Life Sciences: 549 works · 49.5% of their workImmunology and Microbiology: 451 works · 40.7% of their workImmunology: 451 works · 40.7% of their workBiochemistry, Genetics and Molecular Biology: 98 works · 8.8% of their workMolecular Biology: 73 works · 6.6% of their workCancer Research: 24 works · 2.2% of their workHealth Sciences: 329 works · 29.7% of their workMedicine: 329 works · 29.7% of their workOncology: 258 works · 23.3% of their workPulmonary and Respiratory Medicine: 42 works · 3.8% of their workEpidemiology: 29 works · 2.6% of their workEverything else: 231 works · 20.8% of their workTHEIR WORKGordon JamesFreeman1,109works
Life Sciences49%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology45140.7%
    2. Biochemistry, Genetics and Molecular Biology988.8%
    1. Medicine32929.7%
  3. Everything else23120.8%
  1. 1Immunology41% of their works
  2. 2Oncology23% of their works
  3. 3Molecular Biology7% of their works
  4. 4Pulmonary and Respiratory Medicine4% of their works
  5. 5Epidemiology3% of their works
  6. 6Cancer Research2% of their works

Research topics

Which keywords describe Gordon James Freeman's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Natural Killer Cells, NK Cell Recognition, Immunity, Autoimmunity and Antigen Presentation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Cancer Immunotherapy2642 topics
  2. Immune Checkpoint Blockade2611 topic
  3. PD-1 and PD-L12611 topic
  4. NK Cell Recognition2511 topic
  5. Natural Killer Cells2511 topic
  6. Immunity2072 topics
  7. Autoimmunity1932 topics
  8. Antigen Presentation1621 topic
  9. Dendritic Cells1621 topic
  10. Foxp31511 topic
  11. TGF-ß1511 topic
  12. Immunotherapy1312 topics
  13. CAR T Cells1021 topic
  14. Chimeric Antigen Receptor1021 topic
  15. Cancer872 topics
  16. Inflammation872 topics
  17. Activation451 topic
  18. Macrophage451 topic
  19. Galectins421 topic
  20. Immune Regulation421 topic
  21. Metastatic291 topic
  22. Renal Cell Carcinoma291 topic

Where does Gordon James Freeman work?

Gordon James Freeman's main affiliation in the publication record is Dana-Farber Cancer Institute, United States.

How many publications and citations does Gordon James Freeman have?

OpenAlex counts 1,109 works and 133,829 citations for Gordon James Freeman, an h-index of 177, ranking #154 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gordon James Freeman. Posts are plain text and can be reported.